About this consultation

Consultation period
18 May 2018 - 24 August 2018
Borders and security, Public health

Consultation outcome

DownloadXLS - 1.1 MB
DownloadPDF - 563.3 KB


Target group

All citizens, organisations and stakeholders with an interest and/or involvement in issues related to drug and addiction policies are welcome to respond to this consultation.

Objective of the consultation

The Commission is evaluating the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), covering the period 2013 to mid-2018, in line with Article 23 of the EMCDDA Regulation.

The evaluation should provide recommendations on how to enhance the performance of the Agency in undertaking its core activities, including in the areas of trans-national cooperation at European and international level, but also whether the EMCDDA's mandate is still appropriate within the context of an evolved landscape and possible financial constraints. This requires careful assessment of the relevance, effectiveness, efficiency, coherence and EU added value of the EMCDDA's performance.

This open public consultation constitutes an integral part of the process and its objective is to collect the views of all interested parties on the performance of the Agency since 2013 and how this could be further improved.

In parallel, the external consultants will address different stakeholders with targeted questionnaires.

How to submit your response

You can contribute to this public consultation by filling in the online questionnaire.

The questionnaire is accessible in English, French, German, Spanish, Italian and Polish. Contributions may be submitted in any of the official EU languages.

The questionnaire takes approximately 20 minutes to complete.

View the questionnaire

Additional information

EU drugs policy

EMCDDA website

Roadmap for the evaluation of the EMCDDA

EU Drugs Strategy (2013-2020)

EU Action Plan on Drugs (2017-2020)

EMCDDA 3-year work programmes: 2013-2015 and 2016-2018

Regulation (EC) No 1920/2006 on the European Monitoring Centre for Drugs and Drug Addiction (recast) (the "EMCDDA Regulation")

Legal notices

The contributions received will be published on the internet. It is important that you read the specific privacy statement attached to this consultation for information on how your personal data and contribution will be dealt with.

DownloadPDF - 85.3 KB